Your browser doesn't support javascript.
loading
Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop.
Kahrilas, Peter; Anastasiou, Foteini; Bredenoord, Albert J; El Serag, Hashem B; Labenz, Joachim; Mendive, Juan; Savarino, Edoardo V; Sifrim, Daniel; Udrescu, Mihaela; Yadlapati, Rena; Hungin, A Pali.
Afiliación
  • Kahrilas P; Division of Gastroenterology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Anastasiou F; 4th Local Primary Care Team, Municipality Practice and Academic Practice of Heraklion, Crete, Greece.
  • Bredenoord AJ; Department of Gastroenterology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • El Serag HB; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
  • Labenz J; Department of Internal Medicine, Jung-Stilling-Hospital, Siegen, Germany.
  • Mendive J; La Mina Primary Care Academic Centre, Catalan Health Institute, University of Barcelona, Barcelona, Spain.
  • Savarino EV; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
  • Sifrim D; Wingate Institute of Neurogastroenterology, Queen Mary University of London, London, UK.
  • Udrescu M; Individual Family Practice, Bucharest, Romania.
  • Yadlapati R; Division of Gastroenterology, University of California San Diego, La Jolla, California, USA.
  • Hungin AP; Faculty of Medical Sciences, Professor Emeritus, Primary Care and General Practice, Newcastle University, Newcastle upon Tyne, UK.
Dig Dis ; 42(3): 211-220, 2024.
Article en En | MEDLINE | ID: mdl-38513623
ABSTRACT

BACKGROUND:

Despite deprescribing initiatives to curb overutilization of proton pump inhibitors (PPIs), achieving meaningful reductions in PPI use is proving a challenge.

SUMMARY:

An international group of primary care doctors and gastroenterologists examined the literature surrounding PPI use and use-reduction to clarify (i) what constitutes rational PPI prescribing; (ii) when and in whom PPI use-reduction should be attempted; and (iii) what strategies to use when attempting PPI use-reduction. KEY MESSAGES Before starting a PPI for reflux-like symptoms, patients should be educated on potential causes and alternative approaches including dietary and lifestyle modification, weight loss, and relaxation strategies. When commencing a PPI, patients should understand the reason for treatment, planned duration, and review date. PPI use at hospital discharge should not be continued without a recognized indication for long-term treatment. Long-term PPI therapy should be reviewed at least annually. PPI use-reduction should be based on the lack of a rational indication for long-term PPI use, not concern for PPI-associated adverse events. PPI use-reduction strategies involving switching to on-demand PPI or dose tapering, with rescue therapy for rebound symptoms, are more likely to succeed than abrupt cessation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de la Bomba de Protones Límite: Humans Idioma: En Revista: Dig Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de la Bomba de Protones Límite: Humans Idioma: En Revista: Dig Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos